Home > Boards > US Listed > Biotechs > Jounce Therapeutics Inc. (JNCE)

Partner Fund Management, L.P. has filed a new

Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
wiltonio Member Profile
 
Followed By 13
Posts 562
Boards Moderated 0
Alias Born 04/05/16
160x600 placeholder
Quarterly Report (10-q) Edgar (US Regulatory) - 11/7/2019 12:08:15 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 11/7/2019 6:43:51 AM
Jounce Therapeutics Reports Third Quarter 2019 Financial Results GlobeNewswire Inc. - 11/7/2019 6:30:00 AM
Jounce Therapeutics to Present Safety and Preliminary Efficacy Data on JTX-4014 and a Trials in Progress Poster for the Vopra... GlobeNewswire Inc. - 11/5/2019 8:05:00 AM
Jounce Therapeutics to Announce Third Quarter 2019 Financial Results and Host Conference Call on Thursday, November 7, 2019 GlobeNewswire Inc. - 10/31/2019 8:00:05 AM
Jounce Therapeutics to Present Two Posters from the JTX-4014 and Vopratelimab Programs at the Society for Immunotherapy of Ca... GlobeNewswire Inc. - 10/1/2019 6:01:00 PM
Jounce Therapeutics Names Jacquelyn Fahey Sandell as Chief Legal Officer and Corporate Secretary GlobeNewswire Inc. - 9/17/2019 8:00:00 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 9/4/2019 8:52:48 AM
Jounce Therapeutics to Present at Upcoming Investor Conferences in September GlobeNewswire Inc. - 8/28/2019 8:00:00 AM
Quarterly Report (10-q) Edgar (US Regulatory) - 8/7/2019 11:25:18 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 8/7/2019 7:17:18 AM
Jounce Therapeutics Reports Second Quarter 2019 Financial Results GlobeNewswire Inc. - 8/7/2019 6:30:00 AM
Jounce Therapeutics to Announce Second Quarter 2019 Financial Results and Host Conference Call on Wednesday, August 7, 2019 GlobeNewswire Inc. - 7/31/2019 8:00:00 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 7/23/2019 4:05:41 PM
Jounce Therapeutics Announces Update on Strategic Collaboration with Celgene Corporation GlobeNewswire Inc. - 7/23/2019 4:00:00 PM
Jounce Therapeutics Initiates Phase 2 EMERGE Study of Vopratelimab in Combination with Ipilimumab in Patients with Non-Small ... GlobeNewswire Inc. - 6/18/2019 8:00:00 AM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 6/13/2019 10:33:44 AM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 6/13/2019 10:33:19 AM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 6/13/2019 10:33:04 AM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 6/13/2019 10:32:43 AM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 6/13/2019 10:32:18 AM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 6/13/2019 10:31:58 AM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 6/13/2019 10:31:48 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 6/13/2019 10:27:57 AM
Jounce Therapeutics to Present at Upcoming Investor Conferences in June GlobeNewswire Inc. - 6/11/2019 8:00:00 AM
Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist